FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | 1 mg/2.5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | .8 mg/2 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ondansetron Hydrochloride | 8 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Oxytocin | 30 U/500 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Oxytocin | 20 U/1000 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Oxytocin | 20 U/1000 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Oxytocin | 30 U/500 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 50 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 25 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 20 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Rocuronium Bromide | 50 mg/5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Rocuronium Bromide | 100 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 1000 mg/500 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 200 mg/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 400 mg/200 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 400 mg/200 mL; 400 ug/200 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Sodium Bicarbonate | 84 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 100 mg/5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 140 mg/7 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 140 mg/7 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 140 mg/7 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride | 312.5 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Trisodium Citrate Dihydrate | 120 mg/3 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.75 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.75 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 2 g/500 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 2 g/500 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Vecuronium Bromide | 10 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 1 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ephedrine Sulfate | 50 mg/10 mL | 2019-2 | source_no_ndc | 2026-11-14 |